http://cache.io9.com/assets/base/img/thumbs140x140/io9.com.png http://io9.com/tag/ethnopharmacology http://io9.com/tag/ethnopharmacology

In an effort to create "personalized drugs" that work for specific, targeted groups of people, many medical researchers have suggested the adoption of "race-based" medicine. Race-based meds like BiDil, aimed at African Americans with heart disease, are already on the market. But in a fascinating commentary in today's issue of Clinical Pharmacology & Therapeutics, infamous genomics maverick Craig Venter contributes to an article which proves that race-based medicine is doomed to fail. Why? Because "race" as most people understand it has almost nothing to do with genetics — and therefore makes a bad target for tailored medicines. More »
]]> http://io9.com/index.php?op=postcommentfeed&postId=5039142&view=rss&microfeed=true